Bank Of Montreal Collegium Pharmaceutical, Inc Transaction History
Bank Of Montreal
- $192 Billion
- Q1 2025
A detailed history of Bank Of Montreal transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Bank Of Montreal holds 5,762 shares of COLL stock, worth $173,493. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5,762
Previous 4,247
35.67%
Holding current value
$173,493
Previous $121,000
41.32%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding COLL
# of Institutions
254Shares Held
37.2MCall Options Held
61.1KPut Options Held
5.8K-
Black Rock Inc. New York, NY5.79MShares$174 Million0.0% of portfolio
-
Rubric Capital Management LP New York, NY3MShares$90.3 Million2.57% of portfolio
-
Eventide Asset Management, LLC Boston, MA2.64MShares$79.5 Million1.67% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.25MShares$67.6 Million0.0% of portfolio
-
Invesco Ltd. Atlanta, GA1.63MShares$49.1 Million0.01% of portfolio
About COLLEGIUM PHARMACEUTICAL, INC
- Ticker COLL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 34,126,200
- Market Cap $1.03B
- Description
- Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...